Cited by 693T-cell and B-cell ImmunologyImmune responses and vaccinationsGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index; none of the 497 sources its claims cite is checked for support yet.

Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention

Open access

Abstract

Aging is accompanied by remodeling of the immune system. With time, this leads to a decline in immune efficacy, resulting in increased vulnerability to infectious diseases, diminished responses to vaccination, and a susceptibility to age-related inflammatory diseases. An age-associated immune alteration, extensively reported in previous studies, is the reduction in the number of peripheral blood naïve cells, with a relative increase in the frequency of memory cells. These two alterations, together with inflamm-aging, are considered the hallmarks of immunosenescence. Because aging is a plastic process, it is influenced by both nutritional and pharmacological interventions. Therefore, the role of nutrition and of immunomodulation in immunosenescence is discussed, due to the multifactorial influence on these hallmarks. The close connection between nutrition, intake of bioactive nutrients and supplements, immune function, and inflammation demonstrate the key role of dietary strategies as regulators of immune response and inflammatory status, hence as possible modulators of the rate of immunosenescence. In addition, potential options for therapeutic intervention are clarified. In particular, the use of interleukin-7 as growth factor for naïve T cells, the function of checkpoint inhibitors in improving T cell responses during aging and, the potential of drugs that inhibit mitogen-activated protein kinases and their interaction with nutrient signaling pathways are discussed. Finally, it is suggested that the inclusion of appropriate combinations of toll-like receptor agonists may enhance the efficacy of vaccination in older adults.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review defines immunosenescence by three hallmarks—reduced responses to new antigens, memory T-cell accumulation, and inflamm-aging—and surveys nutritional and pharmacological strategies to counter them. It discusses dietary components, IL-7, checkpoint inhibitors, MAPK/mTOR pathway drugs, and TLR-agonist adjuvants as potential interventions, while noting limited and conflicting evidence in older adults.

Key findings

  • The hallmarks of immunosenescence are reduced ability to respond to new antigens, accumulation of memory T cells, and inflamm-aging. At age 50, T cell production is <10% of its previous peak; HCMV-specific clones can occupy >25% of the entire CD8+ pool in older people. A Swedish immunological risk phenotype was present in around 15% of 85-year-olds at baseline and associated with higher 2-, 4-, and 6-year all-cause mortality, but was not confirmed in the Leiden 85-Plus study.
  • Dietary studies report immune effects: zinc supplementation for 12 months (45 mg elemental Zn gluconate/day) lowered infection incidence, raised plasma zinc, and reduced TNF-α and oxidative stress markers; 25 mg zinc sulfate daily for 3 months increased activated T helper and cytotoxic T lymphocytes. A carotenoid mix (30 mg β-carotene, 15 mg lycopene, 9 mg lutein) shifted T cells to a mature phenotype, increased IgA, and increased NK cells; cocoa polyphenols (40 g/day with 500 ml skimmed milk) reduced monocyte VLA-4, CD40, CD36 and circulating P-selectin/ICAM-1; 12 green olives/day for 30 days reduced IL-6 and malondialdehyde in a pilot study of n = 23.
  • Clinical approaches: IL-7 dose-dependently increased circulating CD4+ and CD8+ lymphocytes and decreased Tregs in metastatic cancer patients aged 20–59 years; in HIV-infected patients, repeated recombinant human IL-7 increased naïve and memory CD4+ and mostly naïve CD8+ T cells. A meta-analysis found a 37% reduction in risk of death favoring immune checkpoint inhibitors versus control, though patients ≥75 years obtained less benefit. Low-dose everolimus in >200 older participants improved immune function and decreased PD-1+ lymphocytes; combined BEZ235 and everolimus improved infection control for a year after treatment.
  • Other approaches: combined TLR agonists, including CASAC, enhanced antigen-specific CD8+ T cell responses in aged mice and cytokine secretion by dendritic cells from older adults; in vitro, the combination of TLR7/TLR8 with TLR4 most effectively activated dendritic cells.

Methods

  • Narrative review; no primary experimental data. It synthesizes human trials, mouse models, and ex vivo/in vitro studies on immunosenescence and interventions.
  • Main analysis is a qualitative synthesis of cited literature across innate and acquired immunity, dietary strategies, clinical approaches (IL-7, checkpoint inhibitors, MAPK/mTOR), and TLR-based vaccine adjuvants. No systematic search, meta-analysis, or formal risk-of-bias assessment is described.

Limitations

  • Stated by the authors: heterogeneity among humans (lifestyle and genetic factors) complicates targeted strategies; probiotic/prebiotic randomized controlled trials lack specific biomarkers and reproducibility; fasting studies are limited by small numbers and poor compliance; checkpoint inhibitor data in older adults are conflicting and often lack adequate statistical power; IL-7 effects may require prior restoration of thymic architecture; the correlation between HCMV positivity and impaired responses is controversial; and no evidence exists that males and females respond differently to therapeutic intervention against immunosenescence.
  • Evident from the text: as a narrative review, it does not systematically appraise study quality or quantify pooled effects; many mechanistic claims rely on animal or in vitro/ex vivo data, and several interventions lack data specifically in older adults.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fimmu.2019.02247

Cites

216 of 216 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 497 cited sources checked · 0 supported · 0 flagged

Show all 199 claims

  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 67
76 of 76
  • The paper relies on this without support.

    Gut microbiota plays an active part in healthy status.

    “Gut microbiota that plays an active part in healthy status, is compromised in older adults due to malnutrition, use of medications and immunosenescence itself.”
  • The paper relies on this without support.

    There is a gap in knowledge of the role of immune checkpoint inhibitors in the control of immune response in older patients because data from randomized clinical trials are conflicting and often lack adequate statistical power.

    “However, there is a gap in the knowledge of the role of immune checkpoint inhibitors in the control of immune response in older patients because the data from randomized clinical trials are conflicting and often lack adequate statistical power.”
  • The paper relies on this without support.

    No strong cause-effect relation often exists between the use of probiotics, prebiotics and symbiotics and specific end-points.

    “However, no strong cause-effect relation often exists between their use and specific end-points.”
  • The paper relies on this without support.

    mTOR activity inhibits autophagy.

    “although mTOR activity inhibits autophagy”
  • The paper relies on this without support.

    At high doses, rapamycin is immunosuppressive, blocking both protein synthesis and cell division.

    “At high doses, rapamycin is immunosuppressive, blocking both protein synthesis and cell division.”
  • The paper relies on this without support.

    The increase in lifespan does not coincide with increase in healthspan.

    “However, the increase in lifespan does not coincide with increase in healthspan.”
  • The paper relies on this without support.

    The link between aging and disease is in part a reflection of functional changes in the immune system of older people.

    “The link between aging and disease is in part a reflection of the functional changes in the immune system of older people.”
  • The paper relies on this without support.

    The epilog of an aged immune system is an increased propensity toward reduced resistance to infection, poorer responses to vaccination, and development of age-related diseases.

    “Different factors contribute to the development of age-related immune dysfunction, but the epilog of an aged immune system is an increased propensity toward a reduced resistance to infection, poorer responses to vaccination, and the development of age-related diseases.”
  • The paper relies on this without support.

    HCMV plays a role in the decrease of naïve T cells and increase of memory T cells.

    “Taking into account the role of HCMV in the decrease of naïve T cells and increase of memory T cells”
  • The paper relies on this without support.

    Letermovir inhibits HCMV replication by binding to components of the terminase complex.

    “Letermovir is an antiviral agent that inhibits HCMV replication by binding to components of the terminase complex.”
  • The paper relies on this without support.

    Broad ranges of pharmacological agents with anti-immunosenescence properties have been identified.

    “Broad ranges of pharmacological agents with anti-immunosenescence properties have been identified”
11 of 11

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • p38 is said to both increase and inhibit autophagy

    Minor

    The text says p38-MAPK increases autophagy in senescent CD8+ T cells, but the title of the cited study says p38 signaling inhibits autophagy in those cells.

1 of 1

Citations

Cites

Items 201–216 of 216

Flagged first, then by citations

Research works printed but not linked: 7

  1. Gambino, 2017, Triggering of Toll-like receptors in the elderly. A pilot stdudy relevant for vaccination, 13
  2. Sofi, 2010, Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis, Am J Clin Nutr, 92, 1189, 10.3945/ajcn.2010.2967 · DOI
  3. Chung, 2001, The inflammation hypothesis of aging: molecular modulation by calorie restriction, Ann N Y Acad Sci, 928, 327, 10.1111/j.1749-6632.2001.tb05662.x · DOI · Paper page
  4. Elmadfa, 2009, European Nutrition and Health Report 2009, Ann Nutr Metab, 55, 1, 10.1159/000244607 · DOI
  5. Prasad, 2008, Zinc in human health: effect of zinc on immune cells, Mol Med, 14, 353, 10.2119/2008-00033 · DOI
  6. Meydani, 1997, Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial, JAMA, 277, 1380, 10.1001/jama.1997.03540410058031 · DOI · Paper page
  7. 2000, Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids

Cited by

Sorted by citations

See all 693

Metadata

Authors
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G.
Affiliations
  • University of Palermo (IT)
  • King's College London (GB)
  • University of Molise (IT)
Corresponding author
Caruso, Calogero
Venue
Frontiers in Immunology
Published
2019-09-25
Volume
10
Pages
2247-2247
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2972212509
Cited by
693
References
216
Citations by year
2026: 47 · 2025: 72 · 2024: 109 · 2023: 129 · 2022: 141 · 2021: 132 · 2020: 59 · 2019: 3
FWCI
7.22
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
Bloodwise
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
immunosenescence, inflammaging, naive T cells, memory T cells, aging, dietary intervention, immunomodulation, bioactive nutrients, IL-7, MAPK inhibitors, TLR agonists, vaccination in older adults
MeSH terms
Immunosenescence, Aged, Cell Count, Hematopoietic Stem Cells, Humans, Immunologic Memory, Inflammation, Nutritional Status, T-Lymphocytes, Interleukin-7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review